Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Cox

Showing results (131-140 of 208) with videos related to

Pageof 21
Sort By:
Plos One|August 13, 2013
Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependentMadeleine Hanekom, Elizabeth M Streicher, Doreen Van de Berg, et al.
Experimental Dermatology|June 29, 2018
ATP6V0A2-related cutis laxa in 10 novel patients: Focus on clinical variability and expansion of the phenotypeAude Beyens, Ester Moreno-Artero, Christine Bodemer, et al.
Viruses|November 25, 2023
Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden HamstersEduardo Gallardo-Toledo, Megan Neary, Joanne Sharp, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use caseLee Tatham, Anja Kipar, Joanne Sharp, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2021
BDV Syndrome: An Emerging Syndrome With Profound Obesity and Neurodevelopmental Delay Resembling Prader-Willi SyndromeElisabeth Bosch, Moritz Hebebrand, Bernt Popp, et al.
The European Respiratory Journal|May 5, 2018
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South AfricaErika Mohr, Jennifer Hughes, Anja Reuter, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.
Microbiology Spectrum|July 16, 2024
Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use caseLee Tatham, Anja Kipar, Jo Sharp, et al.
Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.
The New England Journal of Medicine|May 30, 2019
Bedaquiline Microheteroresistance after Cessation of Tuberculosis TreatmentMargaretha de Vos, Serej D Ley, Kristin B Wiggins, et al.
Pageof 21

Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
Plos One|August 13, 2013
Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependentMadeleine Hanekom, Elizabeth M Streicher, Doreen Van de Berg, et al.
Experimental Dermatology|June 29, 2018
ATP6V0A2-related cutis laxa in 10 novel patients: Focus on clinical variability and expansion of the phenotypeAude Beyens, Ester Moreno-Artero, Christine Bodemer, et al.
Viruses|November 25, 2023
Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden HamstersEduardo Gallardo-Toledo, Megan Neary, Joanne Sharp, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use caseLee Tatham, Anja Kipar, Joanne Sharp, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2021
BDV Syndrome: An Emerging Syndrome With Profound Obesity and Neurodevelopmental Delay Resembling Prader-Willi SyndromeElisabeth Bosch, Moritz Hebebrand, Bernt Popp, et al.
The European Respiratory Journal|May 5, 2018
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South AfricaErika Mohr, Jennifer Hughes, Anja Reuter, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.
Microbiology Spectrum|July 16, 2024
Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use caseLee Tatham, Anja Kipar, Jo Sharp, et al.
Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.
The New England Journal of Medicine|May 30, 2019
Bedaquiline Microheteroresistance after Cessation of Tuberculosis TreatmentMargaretha de Vos, Serej D Ley, Kristin B Wiggins, et al.
Pageof 21